ArticleThe Lancet. Rheumatology2022

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.

David Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.